|
| 34154444 | Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study. | J Am Psychiatr Nurses Assoc | 2023 |
| 37516770 | Externally validated deep learning model to identify prodromal Parkinson's disease from electrocardiogram. | Sci Rep | 2023 |
| 37566412 | American Football Play and Parkinson Disease Among Men. | JAMA Netw Open | 2023 |
| 37425910 | Genome-wide association study identifies a new susceptibility locus in <i>PLA2G4C</i> for Multiple System Atrophy. | medRxiv | 2023 |
| 37352617 | Parkinsonism of uncertain clinical significance (PUCS): A proposed new diagnostic entity. | J Neurol Sci | 2023 |
| 37059509 | Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. | Lancet Neurol | 2023 |
| 37458046 | Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression. | J Parkinsons Dis | 2023 |
| 37184848 | Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune. | JAMA Neurol | 2023 |
| 37334615 | What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP). | J Parkinsons Dis | 2023 |
| 37070054 | The Impact of the COVID-19 Pandemic on Care Partners of People with Parkinson's Disease. | Mov Disord Clin Pract | 2023 |
| 37066922 | Proposal for a Biologic Staging System of Parkinson's Disease. | J Parkinsons Dis | 2023 |
| 37427840 | Prevalence and impact of neuropsychiatric symptoms in normal aging and neurodegenerative syndromes: A population-based study from Latin America. | Alzheimers Dement | 2023 |
| 36854767 | LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts. | NPJ Parkinsons Dis | 2023 |
| 36938742 | Trichloroethylene: An Invisible Cause of Parkinson's Disease? | J Parkinsons Dis | 2023 |
| 36892733 | Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT study. | J Patient Rep Outcomes | 2023 |
| 33213556 | Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice. | CNS Spectr | 2022 |
| 35522472 | Enhancing Clinical Information Display to Improve Patient Encounters: Human-Centered Design and Evaluation of the Parkinson Disease-BRIDGE Platform. | JMIR Hum Factors | 2022 |
| 35418456 | Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease. | Neurology | 2022 |
| 36341088 | Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia. | Front Neurol | 2022 |
| 36146181 | Deep Learning for Daily Monitoring of Parkinson's Disease Outside the Clinic Using Wearable Sensors. | Sensors (Basel) | 2022 |
| 35970586 | Path to Parkinson Disease Prevention: Conclusion and Outlook. | Neurology | 2022 |
| 35921450 | Trial of Cinpanemab in Early Parkinson's Disease. | N Engl J Med | 2022 |
| 35248199 | The epidemiology of cognitive function in Parkinson's disease. | Prog Brain Res | 2022 |
| 35147549 | Surveying Global Availability of Parkinson's Disease Treatment. | J Parkinsons Dis | 2022 |
| 35304480 | Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson's disease. | NPJ Parkinsons Dis | 2022 |
| 35300390 | Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study. | Lancet Reg Health Am | 2022 |
| 34602502 | Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables. | J Parkinsons Dis | 2022 |
| 34744053 | Recruitment for Remote Decentralized Studies in Parkinson's Disease. | J Parkinsons Dis | 2022 |
| 34744052 | Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease. | J Parkinsons Dis | 2022 |
| 34373643 | Remote smartphone monitoring of Parkinson's disease and individual response to therapy. | Nat Biotechnol | 2022 |
| 33350601 | Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD). | Ann Clin Transl Neurol | 2021 |
| 33649343 | The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. | NPJ Parkinsons Dis | 2021 |
| 33864229 | Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson's Disease and Dyskinesia. | Neurol Ther | 2021 |
| 33942926 | Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease. | Mov Disord | 2021 |
| 33938021 | Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease. | Ann Neurol | 2021 |
| 34316671 | Video-based Parkinson's disease assessments in a nationwide cohort of Fox Insight participants. | Clin Park Relat Disord | 2021 |
| 33981783 | Current Knowledge on the Evolution of Care Partner Burden, Needs, and Coping in Parkinson's Disease. | Mov Disord Clin Pract | 2021 |
| 33999105 | Bad Air and Parkinson Disease-The Fog May Be Lifting. | JAMA Neurol | 2021 |
| 33321002 | Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder. | Ann Clin Transl Neurol | 2021 |
| 32568112 | Translation, Validation, Diagnostic Accuracy, and Reliability of Screening Questionnaire for Parkinsonism in Three African Countries. | J Parkinsons Dis | 2020 |
| 31999942 | β-adrenoreceptors and the risk of Parkinson's disease. | Lancet Neurol | 2020 |
| 31929122 | EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's Disease. | J Parkinsons Dis | 2020 |
| 31958097 | Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person. | J Parkinsons Dis | 2020 |
| 31774238 | Cervical dystonia incidence and diagnostic delay in a multiethnic population. | Mov Disord | 2020 |
| 32073681 | Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study. | Mov Disord | 2020 |
| 31733690 | Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. | Clin Geriatr Med | 2020 |
| 33058689 | The economic impact of OFF periods in Parkinson disease. | Am J Manag Care | 2020 |
| 33058688 | Exploring the clinical burden of OFF periods in Parkinson disease. | Am J Manag Care | 2020 |
| 33452629 | Therapeutic Advances in Movement Disorders. | Neurotherapeutics | 2020 |
| 33132895 | Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP). | Front Aging Neurosci | 2020 |